Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Feb 29, 2024 12:38pm
45 Views
Post# 35906872

RE:100L Small-scale commercial PGX plant

RE:100L Small-scale commercial PGX plantFrom there maybe PGX turns out more efficient that conservativly expected. They could run an extra shift. They could run a second 100L vessel and double product available. Maybe install a 200L vessel without much extra risk.  

prophetoffactz wrote: Is it correct that it was a 1000L PGX facility that was proposed for the production of 40,000,000 million doses per year of yeast beta glucan as an immune booster? If that is correct the 100L facility expected to produce at small-scale commercial volumes by Q3 2024 could potentially produce 4,000,000 million doses per year of yeast beta glucan immune booster. That's from a single 100L plant.

I asked Copilot what the what the cost per dose of yeast beta glucan is and it came up with $1.42-$1.67 per capsule. CZO could have gold standard quality. Does that suggest C$9 million per year potential revenue at retail? 

Copilot:

commercial plant refers to a facility where goods or products are produced at a commercial scale for the purpose of selling and generating revenue. These plants are designed to operate efficiently and profitably, often producing items for sale in the market. The term “commercial plant” can apply to various industries, including manufacturing, agriculture, and energy production1.

In the context of yeast beta-glucan, which is used as an immune booster, here are some details:

  1. Yeast Beta-Glucan:

  2. Cost and Dosage:



<< Previous
Bullboard Posts
Next >>